Lowest Price Guaranteed
Slides
237
Last Updated
March 2025
View Count
24263
The global life science analytics market is valued at USD 10.79 billion in 2024, is projected to reach USD 11.74 billion in 2025 and USD 23.73 billion by 2035, representing a higher CAGR of 7.3% during the forecast period.
 |
To learn more about this report, request a free sample copy
Life science is a broad discipline that involves in-depth study of living organisms, including humans, microbes, plants and animals. This research generated huge amount of data that can be extracted and analyzed for applications, such as clinical trials, drug discovery, disease identification and whole genome sequencing. Earlier, these life science analytics practices were handled by skilled personnel to make decisions about drug development and future research.
However, managing and analyzing vast amounts of data accurately and effectively with manual approach is prone to errors, which in turn create delays in research and drug development. Additionally, life science data management requires massive labor forces who spend huge time analyzing large volume of data (similar to healthcare analytics).Considering the research delays, high error chances and additional expenses, life science industries begin to adopt advanced analytics tools / technologies for predictive, descriptive and reporting analysis.
With a transformative shift towards advanced analytics tools and technologies, healthcare and life science analytics experts can analyze and interpret massive amounts of data in real time with higher accuracy rate. The adoption of life science analytics tools helps to enhance clinical trial, research outcomes, minimize the chances of errors, and enhance regulatory compliance. Considering the rapid adoption of advanced analytics tools, the market players are continually evolving the latest analytics analytics in pharma and life sciences technologies that can predict, extract and analyze vast amount of data effortlessly.
For instance, in October 2024, Oracle successfully launched Oracle Analytics Intelligence platform for life science. This AI powered data and analytics cloud-scale platform streamline workflow and accelerate data generation by combining disparate data sets into a single intelligent workbench. As stated by Seema Verma (Executive Vice President and General Manager, Oracle Health and Life Sciences), "Oracle continues to deliver game-changing products that modernize and enhance clinical research and tighten the connection between bench and bedside. With Oracle Analytics Intelligence for Life Sciences, we are breaking down the silos that have stifled innovation in the industry and are delivering the tools and intelligence needed to help advance insights and therapies with speed and precision."
It is important to highlight here that industrial players, such as Oracle, IQVIA and Google are focusing on the integration of generative AI technology to streamline life science research data prediction, precision medicine development and supply chain management. Notable, the ongoing strategic initiatives by industrial players and rising demand for advanced analytic tools are likely to maintain a competitive edge in life science analytics market during the forecast period, offering lucrative opportunities to drive innovations in the field.
The market report provide in-depth information about industrial players who are presenting active across various segments of the life science analytics industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2019 | |
| Forecast Period | Till 2035 | |
| Current Market Size | $ 11.74 Billion | |
| Market Size 2035 | $ 23.73 Billion | |
| CAGR (Till 2035) | 7.3% | |
| Type of Component |
|
|
| Type of Analytics |
|
|
| Type of Process |
|
|
| Type of Deliver Mode |
|
|
| Type of Application Area |
|
|
| End User |
|
|
| Geographical Region |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the market report was to estimate the current life science analytics market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of component (software and services), type of analytics (reporting analytics, descriptive analytics, predictive analytics and prescriptive analytics), type of delivery mode (on-demand and on-premise), type of application area (research and development, sales and marketing support, regulatory compliance, supply chain analytics, and pharmacovigilance), end user (medical device companies, pharmaceutical and biotechnology companies, contract research organizations, and other end users), geographical region (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three life science analytics market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of component, the global life science analytics market is segmented into software and services. According to our projection, presently services segment accounts for the highest share (over 55%) of the market. This can be attributed to the fact that life science industry are aiming to adopt third party services to improve analytics workflow and increase resource utilization. Furthermore, outsourcing of analytics tasks optimizes resource allocation, reduce data analysis time and enhance overall performance. Thus, increasing adoption of services by life science industrial experts is likely to be a key reason for the highest share.
It is important to highlight that outsourcing services also reduce the requirement for skilled personnel, software / tools maintenance and time, which significantly contributed to the higher adoption of services. Owing to the increasing preferences for services, this segment is expected to remain dominant and is likely to grow to a higher CAGR during the forecast period.
This segment highlights the distribution of global market across different type of analytics into reporting analytics, descriptive analytics, predictive analytics and prescriptive analytics. Among these, descriptive analytics segment accounts for the largest life science analytics market size (over 40%). This dominance is due to the rising demand for advanced descriptive analytics tools for quantifiable data-driven analysis of historic trends and datasets to gain insight into business circumstances. Furthermore, descriptive analytics tools play a significant role in mining data for drug discovery and development procedures.
However, in the long run, predictive analytics is expected to grow at a higher CAGR during the forecast period. Predictive analytics software / technology is increasingly being adopted by the life science experts for gaining actionable insights about research outcomes, predict future outcomes and helps in making data-driven decisions. Furthermore, predictive analytics tools help researchers to analyze information during drug discovery, development, treatment outcomes and disease progression, which is likely to fuel its demand in the future.
The global market is segmented based on delivery mode into on-demand and on-premise. Currently, on-demand delivery segment dominates the industry and holds majority life science analytics market share (over 50%). This dominance is likely to be the result of high demand for on-demand solutions to access data from remote locations. Moreover, there is a significant increase in the adoption of web-based and cloud-based analytics software and solutions to facilitate data exploration from real world. Additionally, the availability of high-speed internet connectivity and IoT based connectivity has further fueled the demand for on-demand delivery mode. Driven by the increasing adoption, ease of access and high storage capacity, this segment is likely to register a higher CAGR during the forecast period.
Based on the application area, the global market is categorized into research and development, sales and marketing support, regulatory compliance, supply chain analytics, and pharmacovigilance. According to our life science analytics market analysis, currently sales and marketing support segments holds a dominating position and is capturing highest share (nearly 35%) of the market. This can be attributed to the increasing usage of analytical tools / technology for enhancing sales productivity, streamlining marketing campaign work and improving marketability with new consumers. Furthermore, data analytics tools help to make quick data-driven decisions in sales strategies within pharmaceutical companies, which further fueled the demand for analytical tools for sales and marketing support.
However, in the long run, research and development segment is expected to register a substantial CAGR in the market for life science analytics. This lucrative growth is expected to be the result of the growing adoption of analytics tools and solutions in drug discovery, research and drug development. Moreover, life science analytics tools are increasingly adopted for clinical research and trials to gain better insight and reduce errors, facilitating faster drug approval.
The global market is distributed across different end users, such as medical device companies, pharmaceutical and biotechnology companies, contract research organizations, and other end users. According to our life science analytics market forecast, pharmaceutical and biotechnology companies segment occupies the largest share (48%) of the market. This can be attributed to the growing reliance on advanced analytical tools specifically predictive analytical and descriptive analytical tools for clinical trial design, drug discovery and drug development. Furthermore, pharmaceutical and biotechnology companies are adopting analytical tools for efficient management of resources and managing processes.
However, the medical device companies segment is likely to experience lucrative growth, anticipated to grow at a higher CAGR during the forecast period. This unprecedented growth is likely to be the result of increasing usage of analytical solutions for quality management, product quality maintenance and innovations to meet regulatory compliance. Furthermore, medical device companies are also leveraging analytical tools to increase supply chain management performance, which is likely to be a key reason for highest growth rate.
Based on our life science analytics market forecast, presently, North America holds the dominant position, accounting for ~52% share of the market. North America has advanced healthcare infrastructure and life science industrial players in this region are increasingly adopting digital technologies including analytical solutions to increase product development. Additionally, the increasing prevalence of chronic conditions in this region has necessitated the demand for analytical solutions to deliver value-based care.
In Asia-Pacific, the market for life science analytics is expected to register a highest CAGR during the forecast period. This can be attributed to the increasing expenditure on healthcare IT infrastructure and growing awareness about digital technologies in drug discovery and delivery optimal care.
The “Life Science Analytics Market: Industry Trends and Global Forecasts, till 2035” research report features an extensive study of the focus on competitive landscape of strategic initiatives, emerging mega trends, big pharma initiatives, company profiles and key drivers and restraints. The market report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the life science analytics industry. Key takeaways of the market data analysis are briefly discussed below.
Currently, life science analytics market landscape is highly competitive, witnessing the presence of several well-established and new-entrants. The key players of the industry such as Microsoft, Oracle and Google are taking strategic initiatives to drive the development of advanced analytical solutions. For instance, in November 2024, NTT DATA announced the expansion of strategic partnership with Google Cloud to enhance the adoption of generative AI solutions and cloud-based data analytics for life science, healthcare and other businesses. Under this partnership, both companies will combine NTT DATA’s technology, industrial expertise and immersive client base of large companies with Google Cloud’s best-in-class data analytics cloud capabilities and IT to empower businesses to enhance operational efficiency and optimize resource utilization.
Similarly, several analytics solution providing companies are leveraging the competitive edge to accelerate the adoption of analytical solutions across life science industry. Earlier, in July 2024, Indegene entered into strategic collaboration with Microsoft to leverage Microsoft Fabric with an aim of enhancing the data ingestion and refinement process to facilitate smooth reporting and guarantee governance. Ultimately, the partnership will lead to proficient analytics and agility in business operation. As more market players continue to enhance their efforts in this field, we believe that life science analytics market will remain competitive throughout the forecast period.
Some of the potential market drivers that are propelling the industry include rising adoption of big data analytics and digital technologies for data-driven decision-making processes. Notably, life science industry, pharmaceutical and biotechnology companies are adopting analytical solutions to gain insight into disease progression and drug designing. Moreover, these analytical solutions play an essential role in conducting clinical studies with higher precision, thereby increasing the drug approval process. In addition to drug discovery and development, life science industry is adopting analytical solutions for product development, resource management and workflow optimization, which is likely to be a key growth factor for the market.
Despite of growing adoption, the market is witnessing several challenges that may impede the adoption rate. Some of the potential challenges in life science analytics market includes data privacy, integration challenges and high implementation cost. Data analytics solutions and platforms rely on internet connectivity and cloud servers that pose a risk of patient’s data privacy.
Furthermore, life science companies acquire data from multiple resources such as real-world evidence-based data, electronic health record and clinical trials, which create significant challenges in integrating healthcare analytics solutions across diverse platforms. Additionally, high implementation cost of software installation, infrastructure maintenance and qualified personnel may hinder the adoption rate during the forecast period.
Some of the notable market growth factors include rising demand for personalized therapies and value-based care. Notably, personalized therapies is a new cornerstone for healthcare industry that aim to develop preventive, predictive and customized therapies solutions to treat patients. This type of therapy has necessitated the requirement for advanced analytical solutions to uncover the underlying mechanism of diseases and drug development. Additionally, value-based care, lab sustainability and lab automation has further underscored the demand of innovative analytical solutions to streamline the research workflow. It is worth mentioning that industrial players are continually integrating generative AI technology to enhance the data interpretation capabilities with a real-time approach. These factors are collectively contributing to the growth of the market during the forecast period.
Currently, the global market is valued at USD 11.74 billion and is poised to reach at USD 23.73 billion by 2035, representing a higher CAGR of 7.3% during the forecast period. This significant growth is likely to be bolstered by the rising penetration of digital technologies and analytical solutions to optimize the research work and data-driven decision making processes in drug development.
In order to drive innovation, several industrial players are continually leveraging partnerships and collaborations, which is expected to be a key driver for the market. For instance, in October 2024, Microsoft launched latest healthcare AI powered tools in partnership with Providence and Paige.ai. These AI powered models in Azure AI Studio will help healthcare organizations in integrating and analyzing diverse data that ranges from genomics, medical imaging and clinical records. As stated by Carlo Bifulco (Chief Medical Officer, Providence Genomics), “The development of foundational AI models in pathology and medical imaging is expected to drive significant advancements in cancer research and diagnostics. These models can complement human expertise by providing insights beyond traditional visual interpretation and, as we move toward a more integrated, multimodal approach, will reshape the future of medicine.”
Examples of key players engaged in this field of life science analytics (which have also been captured in this report) include Accenture, Amazon Web Services, Axtria, Alteryx, Clarivate, Cognizant, CitiusTech, ExlService Holdings, Oracle, Optum, IBM, IQVIA, Microsoft, MaxisIT, SAS Institute, Saama Technologies, Sisense, ThoughtSphere, ThoughtSpot, Veradigm (Allscripts Healthcare), Veeva Systems and Wipro.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of life science analytics. We have outlined some of these recent initiatives below.